bluebird bio Inc. (BLUE) - Yalpi foyda normasi

bluebird bio, Inc (BLUE) kompaniyasining rasmiy ramzlari

GURU.Markets kunlik grafigidagi yalpi foyda marjasi koeffitsiyenti noyob gen mahsulotlariga bo'lgan elastik bo'lmagan talab tufayli bluebird bio, Inc. (BLUE) kompaniyasining narxlarni belgilash imkoniyatini aks ettiradi. 12.30 qiymati tashqi CMOlarga ishlab chiqarish bog'liqligini hisobga olgan holda, eng so'nggi metrika qiymatini ifodalaydi. Kompaniyaning nuqsonli hujayralarni tuzatishdagi yetakchiligi og'ir patologiyalar uchun atigi bitta muolaja orqali inqilobiy davolash usullarini yaratish imkonini beradi.

BLUE bluebird bio Inc. Yalpi rentabellik (04.07.2022 - 07.06.2025)

bluebirdbio.com (BLUE) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
Fundamental baholash:bluebird bio Inc., BLUE
bluebird bio, Inc. asosiy tovari

Yalpi foyda darajasi tushum va sotilgan tovarlar tannarxi orasidagi farqning umumiy savdoga nisbati sifatida hisoblanadi va bevosita ishlab chiqarish samaradorligini o'lchaydi. Ushbu ko'rsatkich biznesning operatsion xarajatlar va soliqlarni hisobga olguncha foyda keltirish qobiliyatini belgilaydi. Gen terapiyasi ishlab chiqarishining autsorsing qilingani sababli, GURU.Markets platformasidagi tushumning yalpi daromad ulushi bluebird bio, Inc. (BLUE) kompaniyasidagi tashqi kontraktlarni boshqarish samaradorligini aks ettiradi.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi WGS|RARE - Yalpi rentabellik|Beam Tx (BEAM) - Yalpi foyda bo'yicha rentabellik|SRPT (Sarepta Therapeutics Inc) - Yalpi foyda bo'yicha rentabellik|TWST: Yalpi foyda koeffitsiyenti|TXG (10xgenomics.com) - Yalpi marja|NTLA (Intellia Therapeutics, Inc.) - Yalpi foyda koeffitsiyenti|Yalpi rentabellik Stoke Corp (STOK)|Yalpi foyda bo'yicha sotuv rentabelligi BioLife|Yalpi marja WVE (Wave Life Sciences Ltd)|MAZE: Sotuvning yalpi rentabelligi|Sionna Therapeutics, Inc. - Yalpi marja|Yalpi foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Yalpi foyda bo'yicha rentabellik|QURE - Yalpi foyda bo'yicha sotuv rentabelligi|MGTX (MeiraGTx Corp) - Yalpi marja|Yalpi foyda marjasi REGENXBIO Inc. RGNX|Yalpi rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik Pacific Biosciences PACB|Yalpi foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Yalpi marja|Rocket Pharmaceuticals - Yalpi foyda koeffitsiyenti|Sotuvning yalpi rentabelligi 4D Molecular Therapeutics, Inc.|Yalpi foyda marjasi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Yalpi marja|Yalpi foyda marjasi Editas EDIT|Yalpi marja SLN|ProQR Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja CDXS (Codexis, Inc.)|SGMO: Sotuvning yalpi rentabelligi|Nautilus Biotechnology - Yalpi marja|Yalpi foyda normasi MGX (Metagenomi, Inc)|DTIL: Yalpi marja|GBIO: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Boundless Bio Inc.|Yalpi foyda bo'yicha rentabellik Exicure (XCUR)|Yalpi marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Yalpi foyda normasi|Mustang Bio, Inc. - Yalpi foyda bo'yicha rentabellik|RNAZ - Yalpi foyda bo'yicha rentabellik|BNGO: Yalpi foyda bo'yicha rentabellik|APDN (Applied DNA Sciences Inc) - Sotuvning yalpi rentabelligi|ImmunoPrecise (IPA) - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik OMGA (Omega)|Yalpi rentabellik Singular Genomics Systems|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik